鼻咽癌与EB病毒立即早期蛋白的应用进展

赵新星; 张龙城

doi:10.13201/j.issn.1001-1781.2016.13.019

鼻咽癌与EB病毒立即早期蛋白的应用进展

赵新星¹,
张龙城^2, ,

- 1 桂林医学院研究生院(广西桂林, 541004);
- 2 解放军第303医院耳鼻咽喉头颈外科

详细信息

通讯作者: 张龙城,E-mail:zhanglongcheng_303@163.com

中图分类号: R739.6

收稿日期: 2016-01-12

Research of nasopharyngeal carcinoma and the application of epstein-barr virus immediate early protein

ZHAO Xinxing¹,
ZHANG Longcheng^2, ,

More Information

Corresponding author: ZHANG Longcheng, E-mail: zhanglongcheng_303@163.com

Received Date: 12 January 2016

摘要

- 鼻咽癌 /
- EB病毒立即早期蛋白 /
- Zta-IgG/IgA抗体 /
- Rta-IgG抗体
Abstract: Epstein-barr virus is closely related to the occurrence and development of nasopharyngeal carcinoma;EB virus immediate early protein Zta and Rta is the control factor for the virus to enter the replication and cleavage stage.At present,ELISA method is commonly used to detect serum Zta and Rta related antibodies in the clinical as one of the serological indicators for early nasopharyngeal cancer screening and the auxiliary diagnosis.
- nasopharyngeal carcinoma /
- epstein-barr virus immediate early protein /
- Zta-IgG/IgA antibody /
- Rta/IgG antibody

HTML全文

参考文献(52)

[1]	TAYLOR G S,LONG H M,BROOKS J M,et al.The immunology of Epstein-Barr virus-Induced disease[J].Ann Rev Immunol,2015,33:787-821.
[2]	YOUNG L S,RICKINSON A B.Epstein-Barr virus:40years on[J].Nature Rev Cancer,2004,4:757-768.
[3]	VRZALIKOVA K,VOCKERODT M,LEONARDS,et al.Downregulation of BLIMP1-alpha by the EBV oncogene,LMP1,disrupts the plasma cell differentiation program and prevents viral replication in B cells:implications for the pathogenesis of EBVassociated B cell lymphomas[J].Blood,2011,117:5907-5917.
[4]	ZENG M S,LID J,LIU Q L,et al.Genomic sequence analysis of Epstein-Barr Virus strain GDI form a nasopharyngeal carcinoma patient[J].J Vionl,2005,79:15323-15330.
[5]	邓伟,黄天壬,陈万青,等.中国2003-2007年鼻咽癌发病与死亡分析[J].肿瘤,2012,32(3):189-193.
[6]	王承明.病原生物学与免疫学[M].北京:高等教育出版社,2010:2-2.
[7]	ALVES G,MACRINI C M,DE SOUZANASCIMEN-TO P,et al.Detection and expression of Epstein-Barr Virus(EBV)DNA in tissues from penile tumors in Brazil[J].Cancer Lett,2004,215:79-82.
[8]	STEVEN N M,ANNELS N E,KUMAR A,et al.Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response[J].J Exp Med,1997,185:1605-1618.
[9]	TAO Q,SRIVASTAVA G,CHAN A C L,et al.Evidence for lytic infection by Epstein-Barr virus in mucosal lymphocytes instead of nasopharyngeal epithelial cells in normal individuals[J].J Med Virol,1995,45:71-77.
[10]	NIEDOBITEK G,AGATHANGGELOU A,NI-CHOLLS J M.Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma:viral gene expression,tumour cell phenotype,and the role of the lymphoid stroma[J].Seminars Cancer Biol.Academic Press,1996,7:165-174.
[11]	PETOSA C,MORAND P,BAUDIN F,et al.Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein[J].Molecular Cell,2006,21:565-572.
[12]	SINCLAIR A J.Unexpected structure of EpsteinBarr virus lytic cycle activator Zta[J].Trends Microbiol,2006,14:289-291.
[13]	HICKS M R,BALESARIA S,MEDINA-PALAZONC,et al.Biophysical analysis of natural variants of the multimerization region of Epstein-Barr virus lyticswitch protein BZLF1[J].J Virol,2001,75:5381-5384.
[14]	CHANG Y N,DONG D L,HAYWARD G S,et al.The Epstein-Barr virus Zta transactivator:a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif[J].J Virol,1990,64:3358-3369.
[15]	SPECK S H,CHATILA T,FLEMINGTON E.Reactivation of Epstein-Barr virus:regulation and function of the BZLF1 gene[J].Trends Microbiol,1997,5:399-405.
[16]	EL-GUINDY A,HESTON L,MILLER G.A subset of replication proteins enhances origin recognition and lytic replication by the Epstein-Barr virus ZEBRAprotein[J].PLoS Pathog,2010,6:1001054-1001054.
[17]	KALLA M,SCHMEINCK A,BERGBAUER M,et al.AP-1homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome[J].Proc National Academy Sci,2010,107:850-855.
[18]	RAMASUBRAMANYAN S,KANHERE A,OS-BORN K,et al.Genome-wide analyses of Zta binding to the Epstein-Barr virus genome reveals interactions in both early and late lytic cycles and an epigenetic switch leading to an altered binding profile[J].J Virol,2012,86:12494-12502.
[19]	SATO Y,SHIRATA N,KUDOH A,et al.Expression of Epstein-Barr virus BZLF1 immediate-early protein induces p53 degradation independent of MDM2,leading to repression of p53-mediated transcription[J].Virology,2009,388:204-211.
[20]	SWENSON J J,HOLLEY-GUTHRIE E,KENNEY SC.Epstein-Barr virus immediate-early protein BRLF1 interacts with CBP,promoting enhanced BRLF1 transactivation[J].J Virol,2001,75:6228-6234.
[21]	LIU S T.Function of the intercistronic region of BRLF1-BZLF1 bicistronic mRNA in translating the zta protein of Epstein-Barr virus[J].J Virol,2001,75:1142-1145.
[22]	HARDWICK J M,TSE L,APPLEGREN N,et al.The Epstein-Barr virus R transactivator(Rta)contains a complex,potent activation domain with properties different from those of VP16[J].J Virol,1992,66:5500-5508.
[23]	WILLE C K,NAWANDAR D M.Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication[J].J Virol,2013,87:935-950.
[24]	BENTZ G L,LIU R,HAHN A M,et al.EpsteinBarr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta[J].Virology,2010,402:121-128.
[25]	GRUFFAT H,SERGEANT A.Characterization of the DNA-bining site repertoire for the Epstein-Barr virus transcription factor R[J].Nucleic Acids Res,1994,22:1172-1176.
[26]	RAGOCZY T,MILLER G.Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites.[J].JVirol,2001,75:5240-5247.
[27]	林怡廷.EB病毒早期基因BBLF2/3的启动子分析[D].台北:台湾大学.2011.
[28]	LI Y,WEBSTER-CYRIAQUE J,TOMLINSON CC,et al.Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression[J].J Virol,2004,78:4197-4206.
[29]	ADAMSON A L,DARR D,HOLLEY-GUTHRIEE,et al.Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases[J].J Virol,2000,74:1224-1233.
[30]	PEPPERL S,BENNINGER-DÖRING G,MODR-OW S,et al.Immediate-early transactivator Rta of Epstein-Barr virus(EBV)shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes[J].J Virol,1998,72:8644-8649.
[31]	HSU T Y,CHANG Y,WANG P W,et al.Reactivation of Epstein-Barr virus can be triggered by an Rta protein mutated at the nuclear localization signal[J].J General Virol,2005,86:317-322.
[32]	HEILMANN A M,CALDERWOOD M A,JO-HANNSEN E.Epstein-Barr virus LF2 protein regulates viral replication by altering Rta subcellular localization[J].J Virol,2010,84:9920-9931.
[33]	CALDERWOOD,MICHAEL A.The Epstein-Barr Virus LF2 protein inhibits viral replication[J].J Virol,2008,82:8509-8519.
[34]	HEILMANN A M,CALDERWOOD M A.Genomewide analysis of Epstein-Barr virus Rta DNA binding[J].J Virol,2012,86:5151-5164.
[35]	KAWANISHI M.Anti-apoptotic function of the Epstein-Barr virus LMP1 and BHRF1 proteins.Nihon rinsho[J].Japanese J Clin Med,1996,54:1848-1854.
[36]	MARSHALL W L,YIM C,GUSTAFSON E,et al.Epstein-Barr virus encodes a novel homolog of the bcl-2oncogene that inhibits apoptosis and associates with Bax and Bak[J].J Virol,1999,73:5181-5185.
[37]	YOSHIZAKI T,MIWA H,TAKESHITA H,et al.Elevation of antibody against Epstein-Barr virus genes BRLF1 and BZLF1 in nasopharyngeal carcinoma[J].J Cancer Res Clin Oncol,2000,126:69-73.
[38]	CHENG W,CHAN K H,CHEN H,et al.Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum[J].Int J Cancer,2002,97:489-492.
[39]	顾耀亮,张昌卿,吴子柏,等.抗重组EB病毒抗原双重抗体检测血清学诊断鼻咽癌的研究[J].癌症,2003,22(9):903-906.
[40]	胡维维,宗永生,李凤萍,等.六种抗EB病毒抗体检测在鼻咽癌血清学诊断中的比较[J].中国肿瘤临床,2006,33(14):795-798.
[41]	张春艳.EB病毒Zta-P54蛋白在大肠杆菌中的表达,纯化及检测方法的初步探索[D].郑州:郑州大学.2014.
[42]	ZHANG X,ZHANG Y,NIE Y,et al.Serum Zta antibody of Epstein-Barr virus exerts potential function in the diagnosis of nasopharyngeal cancer[J].Tumor Biol,2014,3:6879-6886.
[43]	陈文思.EB病毒重组抗原Rta蛋白的表达及其在鼻咽癌筛查中的应用[D].广州:中山大学.2010.
[44]	FENG P,CHAN S H,SOO M Y R,et al.Antibody response to Epstein-Barr virus Rta protein in patients with nasopharyngeal carcinoma[J].Cancer,2001,92:1872-1880.
[45]	任军,张晓梅,张晓光,等.以Rtac2/3为抗原用于鼻咽癌病人检测的初步研究[J].中华微生物学和免疫学杂志,2006,26(11):1057-1059.
[46]	唐国全,沙慧芳,唐玉竺.血清EB病毒Rta-IgG抗体检测对鼻咽癌的诊断价值[J].广西医学,2014,36(8):1083-1085.
[47]	汪欣,赵素萍,吴旋,等.4种标记蛋白抗体测定在鼻咽癌体检筛查及诊断中的应用[J].检验医学与临床,2011,8(21):2563-2564.
[48]	AI P,WANG T,ZHANG H,et al.Determination of antibodies directed at EBV proteins expressed in both latent and lytic cycles in nasopharyngeal carcinoma[J].Oral Oncol,2013,49:326-331.
[49]	蔡永林,郑裕明,成积儒,等.EB病毒Rta/IgG,EBNA1/IgA,VCA/IgA及EA/IgA抗体与鼻咽癌分期的关系[J].南方医科大学学报,2010,30(3):509-511.
[50]	朱文良.EB病毒Rta蛋白抗体IgG在鼻咽癌诊断中的应用[D].南宁:广西医科大学.2009.
[51]	李晓华,蒙以良,黄衍强,等.基于2008临床分期的鼻咽癌患者EB病毒EBNA1/IgA等抗体水平分析[J].中国卫生检验杂志,2015,24(16):2641-2643.
[52]	罗耀凌,陈浩,彭颂国,等.联合检测EB病毒不同抗体及EB病毒DNA在鼻咽癌血清学诊断中的价值[J].中华医学杂志,2013,93(44):3516-3519.